Anne Beate Vereide
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study
Anticancer Research 2018 DOI
Anne Ørbo,
Marit Arnes,
Anne Beate Vereide,
Bjørn Straume
:
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens
Olesya Popova,
Claes Gøran Tropé,
Erik Rokkones,
Janne Kærn,
Torbjørn Paulsen,
Helga Salvesen
m.fl.:
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
Gynecologic Oncology 2015 DOI
Anne Ørbo,
Anne Beate Vereide,
Marit Arnes,
Inger Pettersen,
Bjørn Straume
:
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
Georg Sager
:
High Concentrations of Progesterone and Mifepristone Mutually Reinforce Cell Cycle Retardation and Induction of Apoptosis
Anticancer Research 2009
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
ragnhild JÆger,
Georg Sager
:
Levonorgestrel, Medroxyprogesterone and Progesterone Cause a Concentration-dependent Reduction in Endometrial Cancer (Ishikawa) Cell Density, and High Concentrations of Progesterone and Mifepristone Act in Synergy
Anticancer Research 2009
Anne Ørbo,
marit Arnes,
Christine Hancke,
Anne Beate Vereide,
Inger Pettersen,
Kurt Larsen
:
Treatment results of endometrial hyperplasia after prospective D-score classification - A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only
Gynecologic Oncology 2008 DOI
Anne Beate Vereide,
Turid Kaino,
Georg Sager,
Marit Arnes,
Anne Ørbo
:
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia
Gynecologic Oncology 2006
Anne Beate Vereide,
Turid Kaino,
Georg B Sager,
Anne Ørbo
:
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: A comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone
Gynecologic Oncology 2005
Anne Beate Vereide,
Marit Arnes,
Bjørn Straume,
Jan Martin Maltau,
Anne Ørbo
:
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone
Gynecologic Oncology 2004
Bjørn Thorvald Greve Moe,
Anne Ørbo,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone: concentration-dependent inhibition of Ishikawa cell proliferation and induction of apoptosis
Virchows Archiv 2011
Anne Ørbo,
Bjørn greve Moe,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone
2007
Anne Beate Vereide,
Anne Ørbo
:
Progestin effects on endometrial growthIn vivo and in vitro studies
UiT Norges arktiske universitet 2006
Anne Beate Vereide,
Anne Ørbo
:
Hva fikk vi ut av pilotstudien
2006
Anne Ørbo,
Anne Beate Vereide
:
Status for levonovastudien
2006
Anne Ørbo,
Anne Beate Vereide
:
Fra forskning til klinisk praksis
2006
Anne Beate Vereide,
Anne Ørbo
:
progestineffekter på endometrievekst
2006
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi
2005
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi
2005
Anne Beate Vereide,
Anne Ørbo
:
Levonovastudien: En oppdatering
2005
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi levonovastudien
2005
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →